Boothbay Fund Management »

Lenz Therapeutics shares owned by Boothbay Fund Management

Quarter-by-quarter ownership of Lenz Therapeutics (LENZ) shares owned by Boothbay Fund Management from 13F filings

Historical chart of Boothbay Fund Management investment in Lenz Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Lenz Therapeutics held by Boothbay Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lenz Therapeutics by Boothbay Fund Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $505k 23k 22.33

More positions owned by Boothbay Fund Management

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Ishares Bitcoin Tr SHS (IBIT)
Fidelity Wise Origin Bitcoin SHS (FBTC)
Grayscale Bitcoin Tr Btc Shs Rep Com Ut (GBTC)
Microstrategy Cl A New Put Option (MSTR)
Bitwise Bitcoin Etf Tr Shs Ben Int (BITB)
Sarepta Therapeutics Put Option (SRPT)
Spdr Ser Tr S&p Biotech Put Option (XBI)
United States Steel Corporation (X)
NVIDIA Corporation Call Option (NVDA)
Cornerstone Strategic Value (CLM)
Amazon Put Option (AMZN)
Humana Call Option (HUM)
Amphenol Corp Cl A Put Option (APH)

View all positions for Boothbay Fund Management

Top funds holding Lenz Therapeutics

RA Capital Management
Falcon Edge Capital
EcoR1 Capital
Samsara BioCapital
72 Investment Holdings
BlackRock
Vanguard Group
Point72 Asset Management
Tang Capital Management
Geode Capital Management
Alyeska Investment Group
State Street Corporation
Ikarian Capital
Board of Trustees of The Leland Stanford Junior University
Wealth Enhancement Advisory Services

View all funds holding Lenz Therapeutics